The effectiveness of policies for reducing dietary trans fat: A systematic review of the evidence;La eficacia de las estrategias para reducir las grasas trans en la dieta: Examen sistemático de los datos disponibles

Bulletin of the World Health Organization

Volumn 91, Issue 4, 2013, Pages 262-269

  Downs, Shauna M ^a   Thow, Anne Marie ^a   Leeder, Stephen R ^a  

^a University of Sydney   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TRANS FATTY ACID;

BLOOD; DIET; FATTY ACID; FOOD POLICY; FOOD SUPPLY; HEALTH IMPACT; MILK; PUBLIC HEALTH;

BIBLIOGRAPHIC DATABASE; BLOOD LEVEL; BREAST MILK; DIET RESTRICTION; FAT CONTENT; FEEDING BEHAVIOR; FOOD COMPOSITION; FOOD CONTROL; FOOD PACKAGING; HUMAN; PEER REVIEW; POLICY; REVIEW; SYSTEMATIC REVIEW;

EID: 84877012534     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.12.111468     Document Type: Review

References (50)

1. Uauy R, Aro A, Clarke R, L'Abbé MR, Mozaffarian D, Skeaff CM, et al. WHO scientific update on trans fatty acids: summary and conclusions. Eur J Clin Nutr 2009;63:S68-75. doi:10.1038/ejcn.2009.15
2. Mozaffarian D, Stampfer MJ. Removing industrial trans fat from foods. BMJ 2010;340:c1826. doi:10.1136/bmj.c1826 PMID:20395265
3. Teegala SM, Willett WC, Mozaffarian D. Consumption and health effects of trans fatty acids: a review. J AOAC Int 2009;92:1250-7. PMID:19916363
4. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med 2006;354:1601-13. doi:10.1056/NEJMra054035 PMID:16611951
5. World Health Organization [Internet]. Web-based consultation on the development of a global monitoring framework and targets for the prevention and control of NCDs. Geneva: World Health Organization; 2012. Available from: http://www.who.int/nmh/events/2012/ncd_discussion_paper/en/index.html [accessed 4 January 2013].
6. From burden to "best buys": reducing the economic impact of non-communicable diseases in low- and middle-income countries. Geneva: World Economic Forum & World Health Organization; 2011. Available from: http://www.who.int/nmh/publications/best_buys_summary.pdf [accessed 4 January 2013].
7. Summary of feedback from Member States on the first discussion paper on the proposed global monitoring framework and indicators and targets for the prevention and control of noncommunicable diseases. Geneva: World Health Organization; 2012. Available from: http://www.who.int/nmh/events/2012/targets_feedback_summary_22032012.pdf [accessed 4 January 2013].
8. Schleifer D. We spent a million bucks and then we had to do something: the unexpected implications of industry involvement in trans fat research. Bull Sci Technol Soc 2011;31:460-71. doi:10.1177/0270467611422837
9. National Health Medical Research Council. How to use the evidence: assessment and application of scientific evidence. Canberra: NHMRC; 2000. Available from: http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/cp69.pdf?q=publications/synopses/_files/cp69.pdf [accessed 4 January 2013].
10. Katan MB. Regulation of trans fats: the gap, the Polder, and McDonald's French fries. Atheroscler Suppl 2006;7:63-6. doi:10.1016/j.atherosclerosissup.2006.04.013 PMID:16713390
11. Temme EH, Millenaar IL, Van Donkersgoed G, Westenbrink S. Impact of fatty acid food reformulations on intake of Dutch young adults. Acta Cardiol 2011;66:721-8. PMID:22299382
12. Colon-Ramos U, Lindsay AC, Monge-Rojas R, Greaney ML, Campos H, Peterson KE. Translating research into action: a case study on trans fatty acid research and nutrition policy in Costa Rica. Health Policy Plan 2007;22:363-74. doi:10.1093/heapol/czm030 PMID:17951318
13. Monge-Rojas R, Colon-Ramos U, Jacoby E, Mozaffarian D. Voluntary reduction of trans-fatty acids in Latin America and the Caribbean: current situation. Rev Panam Salud Publica 2011;29:126-9. doi:10.1590/S1020-49892011000200008 PMID:21437370
14. Stender S, Astrup A, Dyerberg J. What went in when trans went out? N Engl J Med 2009;361:314-6. doi:10.1056/NEJMc0903380 PMID:19605843
15. Lee JH, Adhikari P, Kim SA, Yoon T, Kim IH, Lee KT. Trans fatty acids content and fatty acid profiles in the selected food products from Korea between 2005 and 2008. J Food Sci 2010;75:C647-52. doi:10.1111/j.1750-3841.2010.01737.x PMID:21535532
16. Trans fat: going...going... Washington: Centre for Science in the Public Interest; 2005. Available from: http://transfreeamerica.org/transfree.pdf [accessed 4 January 2013].
17. Albers MJ, Harnack LJ, Steffen LM, Jacobs DR. 2006 marketplace survey of trans-fatty acid content of margarines and butters, cookies and snack cakes, and savory snacks. J Am Diet Assoc 2008;108:367-70. doi:10.1016/j.jada.2007.10.045 PMID:18237584
18. Niederdeppe J, Frosch DL. News coverage and sales of products with trans fat: effects before and after changes in federal labeling policy. Am J Prev Med 2009;36:395-401. doi:10.1016/j.amepre.2009.01.023 PMID:19269126
19. Mozaffarian D, Jacobson MF, Greenstein JS. Food reformulations to reduce trans fatty acids. N Engl J Med 2010;362:2037-9. doi:10.1056/NEJMc1001841 PMID:20505187
20. Van Camp D, Hooker NH, Li C-TJ. Changes in fat content of US snack foods in response to mandatory trans fat labelling. Public Health Nutr 2012;15:1130-7. doi:10.1017/S1368980012000079
21. Vesper HW, Kuiper HC, Mirel LB, Johnson CL, Pirkle JL. Levels of plasma trans-fatty acids in non-Hispanic white adults in the United States in 2000 and 2009. JAMA 2012;307:562-3. doi:10.1001/jama.2012.112 PMID:22318273
22. Beninca C, Zanoelo EF, de Lima Luz LF, Spricigo CB. Trans fatty acids in margarines marketed in Brazil: content, labelling regulations and consumer information. Eur J Lipid Sci Technol 2009;111:451-8. doi:10.1002/ejlt.200800185
23. Friesen R, Innis SM. Trans fatty acids in human milk in Canada declined with the introduction of trans fat food labeling. J Nutr 2006;136:2558-61. PMID:16988126
24. Ricciuto L, Lin K, Tarasuk V. A comparison of the fat composition and prices of margarines between 2002 and 2006, when new Canadian labelling regulations came into effect. Public Health Nutr 2009;12:1270-5. doi:10.1017/S1368980008003868 PMID:18986592
25. Ratnayake WMN, L'Abbe MR, Mozaffarian D. Nationwide product reformulations to reduce trans fatty acids in Canada: when trans fat goes out, what goes in? Eur J Clin Nutr 2009;63:808-11. doi:10.1038/ejcn.2008.39 PMID:18594558
26. Ratnayake WMN, L'Abbe MR, Farnworth S, Dumais L, Gagnon C, Lampi B et al. Trans fatty acids: current contents in Canadian foods and estimated intake levels for the Canadian population. J AOAC Int 2009;92:1258-76. PMID:19916364
27. Angell SY, Silver LD, Goldstein GP, Johnson CM, Deitcher DR, Frieden TR et al. Cholesterol control beyond the clinic: New York City's trans fat restriction. Ann Intern Med 2009;151:129-34. PMID:19620165
28. Angell SY, Cobb LK, Curtis CJ, Konty KJ, Silver LD. Change in trans fatty acid content of fast-food purchases associated with New York City's restaurant regulation: a pre-post study. Ann Intern Med 2012;157:81-6. PMID:22801670
29. Preventing heart disease through public health regulation: Boston's artificial trans fat ban. Boston: Boston Public Health Commission; 2009.
30. King County [Internet]. Performance, strategy and budget. Healthy eating, active living. Seattle: King County; 2010. Available from: http://your.kingcounty.gov/aimshigh/2009/search2.asp?HEHePmHealthyEat [accessed 4 January 2013].
31. Measuring up: an evaluation of the BC trans fat initiative June 2010. Vancouver: Government of British Columbia; 2012. Available from: http://www.restricttransfat.ca/media/upload/file/Trans%20Fat%20Evaluation-June%202010%20Final.pdf [accessed 4 January 2013].
32. Stender S, Dyerberg J, Astrup A. High levels of industrially produced trans fat in popular fast foods. N Engl J Med 2006;354:1650-2. doi:10.1056/NEJMc052959 PMID:16611965
33. Stender S, Dyerberg J, Bysted A, Leth T, Astrup A. A trans world journey. Atheroscler Suppl 2006;7:47-52. doi:10.1016/j.atherosclerosissup.2006.04.011 PMID:16713385
34. Stender S, Dyerberg J, Astrup A. Consumer protection through a legislative ban on industrially produced trans fatty acids in foods in Denmark. Scand J Food Nutr 2006;50:155-60. doi:10.1080/17482970601069458
35. Leth T, Jensen HG, Mikkelsen AAE, Bysted A. The effect of the regulation on trans fatty acid content in Danish food. Atheroscler Suppl 2006;7:53-6. doi:10.1016/j.atherosclerosissup.2006.04.019 PMID:16713397
36. Colon-Ramos U, Baylin A, Campos H. The relation between trans fatty acid levels and increased risk of myocardial infarction does not hold at lower levels of trans fatty acids in the Costa Rican food supply. J Nutr 2006;136:2887-92. PMID:17056818
37. Coombes R. Trans fats: chasing a global ban. BMJ 2011;343:d5567. doi:10.1136/bmj.d5567 PMID:21900347
38. Ricciuto L, Ip H, Tarasuk V. The relationship between price, amounts of saturated and trans fats, and nutrient content claims on margarines and oils. Can J Diet Pract Res 2005;66:252-5. doi:10.3148/66.4.2005.252 PMID:16332300
39. Aggarwal A, Monsivais P, Drewnowski A. Nutrient intakes linked to better health outcomes are associated with higher diet costs in the US. PLoS One 2012;7:e37533. doi:10.1371/journal.pone.0037533 PMID:22662168
40. Agrawal A, Gupta R, Varma K, Mathur B. High trans fatty acid content in common Indian fast foods. Nutr Food Sci 2008;38:564-9. doi:10.1108/00346650810920178
41. Downs SM, Thow AM, Ghosh-Jerath S, McNab J, Reddy KS, Leeder SR. From Denmark to Delhi: the multisectoral challenge of regulating trans fat in India. Public Health Nutr 20 November 2012:1-8.
42. Healthy oils and the elimination of industrially produced trans fatty acids in the Americas: initiative for the prevention and control of chronic diseases. Washington: Pan American Health Organization; 2008. Available from: http://www.healthycaribbean.org/nutrition_and_diet/documents/TransFats.pdf [accessed 4 January 2013].
43. L'Abbe MR, Stender S, Skeaff CM, Ghafoorunissa, Tavella M. Approaches to removing trans fats from the food supply in industrialized and developing countries. Eur J Clin Nutr 2009;63:S50-67. doi:10.1038/ejcn.2009.14 PMID:19190645
44. Mozaffarian D, Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur J Clin Nutr 2009;63:S22-33. doi:10.1038/sj.ejcn.1602976 PMID:19424216
45. Stuckler D, McKee M, Ebrahim S, Basu S. Manufacturing epidemics: the role of global producers in increased consumption of unhealthy commodities including processed foods, alcohol, and tobacco. PLoS Med 2012;9:e1001235. doi:10.1371/journal.pmed.1001235 PMID:22745605
46. Bhushan R. PepsiCo takes 'snack smart' logo off Lays, moves away from rice bran oil to cut costs. Economic Times of India. 26 March 2012. Available from: http://articles.economictimes.indiatimes.com/2012-03-26/news/31240352_1_rice-bran-oil-snack-foods-kurkure [accessed 4 January 2013].
47. Scott-Thomas C. Foodnavigator-usa.com [Internet]. City of Cleveland sues Ohio State for blocking trans fat ban. Montpellier: William Reed Business Media SAS; 5 January 2012. Available from: http://www.foodnavigator-usa.com/Regulation/City-of-Cleveland-sues-Ohio-State-for-blocking-trans-fat-ban [accessed 4 January 2013].
48. Perez-Ferrer C, Lock K, Rivera JA. Learning from international policies on trans fatty acids to reduce cardiovascular disease in low- and middle-income countries, using Mexico as a case study. Health Policy Plan 2010;25:39-49. doi:10.1093/heapol/czp040 PMID:19741052
49. Astrup A. The trans fatty acid story in Denmark. Atheroscler Suppl 2006;7:43-6. doi:10.1016/j.atherosclerosissup.2006.04.010 PMID:16723283
50. Remig V, Franklin B, Margolis S, Kostas G, Nece T, Street JC. Trans fats in America: a review of their use, consumption, health implications, and regulation. J Am Diet Assoc 2010;110:585-92. doi:10.1016/j.jada.2009.12.024 PMID:20338284